The July schedule prioritizes technical and operational advancements, with a heavy emphasis on clinical trial strategy and laboratory innovation. Key sessions include deep dives into ICH E6(R3) risk expectations, patient recruitment methodologies, and the application of AI in regulated software development and quality management. Experts will also address the complexities of commercialization, pharmacovigilance, and the evolving landscape of European market expansion, with a specific look at lessons from Latvia.
Beyond regulatory and clinical topics, the calendar covers emerging trends in food innovation and manufacturing efficiency. Sessions such as "The Future of Healthy Aging" and discussions on reducing downstream bottlenecks in biopharmaceutical production highlight the breadth of the upcoming series. All webinars are hosted by industry leaders and remain open for registration through the Xtalks portal, providing a platform for practitioners to gain insights into data quality, patient-centered trial design, and preclinical research translation.
Comments (0)
No comments yet. Be the first!